Dental Care Clinics in Hato Rey, PR Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Grupo Dental Dres Torrech Cabrero Dentist Medicare: Not Enrolled in Medicare Practice Location: Urb Floral Park #7, Ruiz Belois, Hato Rey, PR 00917 Phone: 787-753-7112 Fax: 787-274-8968 |
Mairym Delgado Roman P.s.c. Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 400 F. D. Roosevelt Ave Suite 506, Hato Rey, PR 00918 Phone: 787-250-7841 |
Sleep Apnea Dental Solutions Of Puerto Rico Psc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 715 Ave. Ponce De Leon, Parada 37 1/2, Hospital Auxilio Mutuo, Hato Rey, PR 00918 Phone: 787-758-2000 Fax: 787-771-7917 |
Basic Dental Clinic Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: Ave Munoz Rivera 402, Hato Rey, PR 00918 Phone: 787-751-6784 |
Clinica Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 420 Ave. Ponce De Leon, Cond. Midtown Suite 602, Hato Rey, PR 00919 Phone: 787-282-5400 |
Km Dental, C.s.p. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 576 Ave. Cesar Gonzalez, Doral Bank Center Ofic. 307, Hato Rey, PR 00918 Phone: 787-753-1475 Fax: 787-731-2261 |
Melvin Hernandez Psc Dental Offices Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: Domenech 315, Hato Rey, PR 00918 Phone: 787-754-0600 Fax: 787-767-4976 |
News Archive
Centerphase Solutions and Mayo Clinic collaborate to speed up clinical trials for new medical treatments
Centerphase has entered into a collaboration with Mayo Clinic to speed the introduction of new medical treatments developed by the biopharmaceutical industry. The Company addressed the root causes historically plaguing the clinical trials process: the lack of a systematic, structured approach for evaluating and optimizing protocols and the tremendous burdens associated with trial start-up administration.
Bioniche updates on phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
Morgridge researchers reveal complex viral replication process in unprecedented detail
In the fight against the viruses that invade everyday life, seeing and understanding the battleground is essential. Scientists at the Morgridge Institute for Research have, for the first time, imaged molecular structures vital to how a major class of viruses replicates within infected cells.
Light-driven protein has potential to become key tool for optogenetics
Biophysicists have developed a hypothesis to explain the function of a light-driven protein which pumps sodium ions across a cell membrane, and they have revealed the key structural feature of these pumps. The scientists see these sodium pumps as being highly promising tools in using light signals to control nerve cells – which is exactly what is involved in the new scientific field of optogenetics.
Elderly may be undertreated for cardiac disease
Not enough elderly people are being prescribed statins, argue researchers in the BMJ.
› Verified 5 days ago